{
    "profile_id": "glebzhdanov",
    "first_name": "Gleb",
    "last_name": "Zhdanov",
    "sub_title": "Investment Manager (Pharma/BioTech/MedTech)",
    "profile_picture": "https://media.licdn.com/dms/image/C4E03AQEwJIS83ZpS1g/profile-displayphoto-shrink_800_800/0/1662467522655?e=1701302400&v=beta&t=CPlocs_vYsxN_GDUTrp3-HcqddOj65O8doUsZTXiuuU",
    "background_image": "https://media.licdn.com/dms/image/D4E16AQGVmFtqJGlVnw/profile-displaybackgroundimage-shrink_350_1400/0/1694885887480?e=1701302400&v=beta&t=THjek_Az3l320y8sIa7tDtfZvdj-xXKEohmwSZRcr7E",
    "profile_type": "personal",
    "entity_urn": "ACoAACy-SGwBT1ny9SECXuXtV-0A3-QNE0712XU",
    "object_urn": 750667884,
    "birth_date": null,
    "summary": "An investment manager covering therapeutic molecules, medical devices, and diagnostic tools (4 years in venture capital and pharmaceutical portfolio consulting) primarily on North America, Europe, and China markets. Responsible for revealing investment opportunities and risks from scientific, market, IP and financial perspectives. Holding an MSc degree and having an advanced research background in medical biotechnology with 9 scientific articles. Willing to provide rational investment decisions while maximizing value for patients.",
    "location": {
        "country": "Netherlands",
        "short": "Nijmegen, Gelderland",
        "city": "Nijmegen",
        "state": "Gelderland",
        "default": "Nijmegen, Gelderland, Netherlands"
    },
    "premium": false,
    "influencer": false,
    "treasury_media": [],
    "languages": {
        "primary_locale": {
            "country": "US",
            "language": "en"
        },
        "supported_locales": [
            {
                "country": "US",
                "language": "en"
            }
        ],
        "profile_languages": [
            {
                "name": "English",
                "proficiency": "FULL_PROFESSIONAL"
            },
            {
                "name": "Russian",
                "proficiency": "NATIVE_OR_BILINGUAL"
            }
        ]
    },
    "industry": "Pharmaceuticals",
    "education": [
        {
            "date": {
                "start": {
                    "month": null,
                    "day": null,
                    "year": 2023
                },
                "end": {
                    "month": null,
                    "day": null,
                    "year": 2025
                }
            },
            "school": {
                "name": "Radboud University",
                "logo": "https://media.licdn.com/dms/image/C4E0BAQHgdni-2v0psQ/company-logo_400_400/0/1670846116863?e=1703721600&v=beta&t=a4mqpMCP_swOQ-RhyswHhGYJT1FDXZvwwsXJKNR_DHA",
                "url": "https://www.linkedin.com/school/radboud-university-nijmegen/"
            },
            "degree_name": "Master's degree",
            "field_of_study": "Pharmacoeconomics/Pharmaceutical Economics",
            "grade": null
        },
        {
            "date": {
                "start": {
                    "month": null,
                    "day": null,
                    "year": 2016
                },
                "end": {
                    "month": null,
                    "day": null,
                    "year": 2022
                }
            },
            "school": {
                "name": "Lomonosov Moscow State University (MSU)",
                "logo": "https://media.licdn.com/dms/image/C560BAQFafJR7i-j8EA/company-logo_400_400/0/1557584831531?e=1703721600&v=beta&t=T5giv640_VArDQ0WugHiSuDnXtFs5AgtMELtRC5C3mQ",
                "url": "https://www.linkedin.com/school/%D0%BC%D0%BE%D1%81%D0%BA%D0%BE%D0%B2%D1%81%D0%BA%D0%B8%D0%B9-%D0%B3%D0%BE%D1%81%D1%83%D0%B4%D0%B0%D1%80%D1%81%D1%82%D0%B2%D0%B5%D0%BD%D0%BD%D1%8B%D0%B9-%D1%83%D0%BD%D0%B8%D0%B2%D0%B5%D1%80%D1%81%D0%B8%D1%82%D0%B5%D1%82-%D0%B8%D0%BC.-%D0%BC.%D0%B2.-%D0%BB%D0%BE%D0%BC%D0%BE%D0%BD%D0%BE%D1%81%D0%BE%D0%B2%D0%B0-%D0%BC%D0%B3%D1%83-/"
            },
            "degree_name": "Master of Science - MS",
            "field_of_study": "Bioorganic chemistry",
            "grade": "4,71/5"
        }
    ],
    "patents": [],
    "awards": [],
    "certifications": [
        {
            "name": "Lead & Invest In Life Sciences: From Lab to IPO",
            "date": {
                "start": {
                    "month": 5,
                    "day": null,
                    "year": 2023
                },
                "end": {
                    "month": null,
                    "day": null,
                    "year": null
                }
            },
            "authority": "GATELEAD \u2014 Global Advanced Technology Entrepreneurship & Leadership School",
            "url": "https://credsverse.com/credentials/fb828007-4222-4344-a436-60f512b89ea7",
            "license_number": "fb828007-4222-4344-a436-60f512b89ea7",
            "display_source": "credsverse.com",
            "company": {
                "id": null,
                "name": "GATELEAD \u2014 Global Advanced Technology Entrepreneurship & Leadership School",
                "logo": "https://media.licdn.com/dms/image/C4E0BAQGsEQzoxYJ59A/company-logo_400_400/0/1647876349486?e=1703721600&v=beta&t=Y284HWXSvXazkyvg-dxyCVtdbcAhATXPjfSKvbBxKhE",
                "url": null
            }
        },
        {
            "name": "IELTS Academic, overall band score 8.0/9.0",
            "date": {
                "start": {
                    "month": 8,
                    "day": null,
                    "year": 2022
                },
                "end": {
                    "month": 8,
                    "day": null,
                    "year": 2024
                }
            },
            "authority": "IELTS Official",
            "url": null,
            "license_number": "22AM001004ZHDG001A",
            "display_source": null,
            "company": {
                "id": null,
                "name": "IELTS Official",
                "logo": "https://media.licdn.com/dms/image/C4E0BAQEs97UO-cXCvw/company-logo_400_400/0/1670511656719?e=1703721600&v=beta&t=HLvVr_-50zLzEWkOz9inxE-41Ed9kYdSW4M9CbnH-vw",
                "url": null
            }
        }
    ],
    "organizations": [],
    "projects": [],
    "publications": [
        {
            "name": "Aptasensors Based on Track-Etched Membranes Coated with a Nanostructured Silver Layer for Influenza A and B Virus Detection",
            "publisher": "Bulletin of the Russian Academy of Sciences: Physics",
            "url": "https://link.springer.com/article/10.3103/S1062873822700873",
            "date": {
                "month": null,
                "day": null,
                "year": 2023
            },
            "authors": [
                {
                    "type": "standardizedContributor",
                    "first_name": "Gleb",
                    "last_name": "Zhdanov",
                    "name": null,
                    "headline": "Investment Manager (Pharma/BioTech/MedTech)"
                }
            ]
        },
        {
            "name": "Improvement of Seed-Mediated Growth of Gold Nanoparticle Labels for DNA Membrane-Based Assays",
            "publisher": "Biosensors",
            "url": "https://www.mdpi.com/2079-6374/13/1/2",
            "date": {
                "month": null,
                "day": null,
                "year": 2022
            },
            "authors": [
                {
                    "type": "standardizedContributor",
                    "first_name": "Gleb",
                    "last_name": "Zhdanov",
                    "name": null,
                    "headline": "Investment Manager (Pharma/BioTech/MedTech)"
                }
            ]
        },
        {
            "name": "Model of the SARS-CoV-2 Virus for Development of a DNA-Modified, Surface-Enhanced Raman Spectroscopy Sensor with a Novel Hybrid Plasmonic Platform in Sandwich Mode",
            "publisher": "Biosensors",
            "url": "https://www.mdpi.com/2079-6374/12/9/768",
            "date": {
                "month": null,
                "day": null,
                "year": 2022
            },
            "authors": [
                {
                    "type": "standardizedContributor",
                    "first_name": "Gleb",
                    "last_name": "Zhdanov",
                    "name": null,
                    "headline": "Investment Manager (Pharma/BioTech/MedTech)"
                }
            ]
        },
        {
            "name": "SERS-based biosensor with Raman-active external responsive element for rapid determination of adenosine monophosphate",
            "publisher": "Analytica Chimica Acta",
            "url": "https://www.sciencedirect.com/science/article/abs/pii/S0003267022007115?via%3Dihub",
            "date": {
                "month": null,
                "day": null,
                "year": 2022
            },
            "authors": [
                {
                    "type": "standardizedContributor",
                    "first_name": "Gleb",
                    "last_name": "Zhdanov",
                    "name": null,
                    "headline": "Investment Manager (Pharma/BioTech/MedTech)"
                }
            ]
        },
        {
            "name": "A Combination of Membrane Filtration and Raman-Active DNA Ligand Greatly Enhances Sensitivity of SERS-Based Aptasensors for Influenza A Virus",
            "publisher": "Frontiers in Chemistry",
            "url": "https://www.frontiersin.org/articles/10.3389/fchem.2022.937180/full",
            "date": {
                "month": null,
                "day": null,
                "year": 2022
            },
            "authors": [
                {
                    "type": "standardizedContributor",
                    "first_name": "Gleb",
                    "last_name": "Zhdanov",
                    "name": null,
                    "headline": "Investment Manager (Pharma/BioTech/MedTech)"
                }
            ]
        },
        {
            "name": "Using a Biosensor Based on Surface-Enhanced Raman Scattering to Identify Influenza Viruses in Biological Fluids",
            "publisher": "Bulletin of the Russian Academy of Sciences: Physics",
            "url": "https://link.springer.com/article/10.3103/S1062873822040293",
            "date": {
                "month": null,
                "day": null,
                "year": 2022
            },
            "authors": [
                {
                    "type": "standardizedContributor",
                    "first_name": "Gleb",
                    "last_name": "Zhdanov",
                    "name": null,
                    "headline": "Investment Manager (Pharma/BioTech/MedTech)"
                }
            ]
        },
        {
            "name": "SERS-Based Aptasensor for Rapid Quantitative Detection of SARS-CoV-2",
            "publisher": "Nanomaterials",
            "url": "https://www.mdpi.com/2079-4991/11/6/1394",
            "date": {
                "month": null,
                "day": null,
                "year": 2021
            },
            "authors": [
                {
                    "type": "standardizedContributor",
                    "first_name": "Gleb",
                    "last_name": "Zhdanov",
                    "name": null,
                    "headline": "Investment Manager (Pharma/BioTech/MedTech)"
                }
            ]
        },
        {
            "name": "Energy Dissipation Hypothesis Applied to Enhance the Affinity of Thrombin Binding Aptame",
            "publisher": "Biophysica",
            "url": "https://www.mdpi.com/2673-4125/1/2/14",
            "date": {
                "month": null,
                "day": null,
                "year": 2021
            },
            "authors": [
                {
                    "type": "standardizedContributor",
                    "first_name": "Gleb",
                    "last_name": "Zhdanov",
                    "name": null,
                    "headline": "Investment Manager (Pharma/BioTech/MedTech)"
                }
            ]
        },
        {
            "name": "SERS-Based Colloidal Aptasensors for Quantitative Determination of Influenza Virus",
            "publisher": "international journal of molecular sciences",
            "url": "https://www.mdpi.com/1422-0067/22/4/1842",
            "date": {
                "month": null,
                "day": null,
                "year": 2021
            },
            "authors": [
                {
                    "type": "standardizedContributor",
                    "first_name": "Gleb",
                    "last_name": "Zhdanov",
                    "name": null,
                    "headline": "Investment Manager (Pharma/BioTech/MedTech)"
                }
            ]
        }
    ],
    "courses": [],
    "test_scores": [],
    "position_groups": [
        {
            "company": {
                "id": null,
                "name": "Pharmstandard JSC (Pharmstandard Ventures)",
                "logo": null,
                "url": null,
                "employees": {
                    "start": null,
                    "end": null
                }
            },
            "date": {
                "start": {
                    "month": 9,
                    "day": null,
                    "year": 2021
                },
                "end": {
                    "month": null,
                    "day": null,
                    "year": null
                }
            },
            "profile_positions": [
                {
                    "location": "Moscow, Russia",
                    "date": {
                        "start": {
                            "month": 9,
                            "day": null,
                            "year": 2021
                        },
                        "end": {
                            "month": null,
                            "day": null,
                            "year": null
                        }
                    },
                    "company": "Pharmstandard JSC (Pharmstandard Ventures)",
                    "description": "An investment division managing an international VC fund and providing consultancy for Pharmstandard JSC \u2013 the largest pharmaceutical group in Russia with ~$4B in revenue and 7000+ employees in 2021. \nMy division executes medical, scientific, and financial due diligence of companies for M&A, equity investments, and in-licensing deals.\nPrimary responsibilities (reporting to CEO, investment and business development directors):\n- Conducting technical and commercial due diligence of private companies (preclinical-phase 2 clinical stages) and their pipelines (North America and Europe markets) to identify investment opportunities and risks while fulfilling unmet medical needs and maximizing ROI.\n- Assessment of in-licensing candidates from China and South Korea for complementing strategic Pharmstandard\u2019s portfolio according to therapy guidelines, epidemiology models, reimbursement protocols, and market estimations.\n- Consulting the board observer of EnGene (portfolio company, gene therapy of NMIBC) on scientific and clinical data; estimation of prospective inflection points for forecasting of exit scenarios.",
                    "title": "Investment Manager",
                    "employment_type": "Full-time"
                }
            ]
        },
        {
            "company": {
                "id": 36157505,
                "name": "Unicorn Capital Partners ($65M biomedicine VC fund)",
                "logo": "https://media.licdn.com/dms/image/C4D0BAQGaiZt2R4vzsw/company-logo_400_400/0/1579718453631?e=1703721600&v=beta&t=NiT0WjzSdYzzPwe1_s7ymv2lzLhXIuMxLCyJvdLYnxU",
                "url": "https://www.linkedin.com/company/unicpartners/",
                "employees": {
                    "start": 2,
                    "end": 10
                }
            },
            "date": {
                "start": {
                    "month": 6,
                    "day": null,
                    "year": 2020
                },
                "end": {
                    "month": 6,
                    "day": null,
                    "year": 2021
                }
            },
            "profile_positions": [
                {
                    "location": "Moscow, Russia",
                    "date": {
                        "start": {
                            "month": 6,
                            "day": null,
                            "year": 2020
                        },
                        "end": {
                            "month": 6,
                            "day": null,
                            "year": 2021
                        }
                    },
                    "company": "Unicorn Capital Partners",
                    "description": "Unicorn Capital Partners is a healthcare venture fund with $65M under management, which invests in startups developing therapeutic molecules, medical devices, and digital health startups. \nPrimary functions (reported to CEO and partners): \n- Sourced hundreds of private breakthrough healthcare startups in preclinical and early clinical stages; conducted scientific due diligence for multiple companies. \n- Worked with an investment manager on building and updating VC valuation DCF models (including rNPV, IRR, comparables, sales and market penetration forecasting ). \n- Provided full analytical responsibility for $XM investment deal in the biomedical startup (a preclinical stage peptide for metabolic diseases) from the pitch deck to the investment committee with GPs and LPs. The investment would allow to complete preclinical, phase 1 and phase 2 clinical studies.",
                    "title": "Junior Analyst",
                    "employment_type": "Contract"
                }
            ]
        },
        {
            "company": {
                "id": null,
                "name": "Pharmstandard JSC (Pharmstandard Ventures)",
                "logo": null,
                "url": null,
                "employees": {
                    "start": null,
                    "end": null
                }
            },
            "date": {
                "start": {
                    "month": 6,
                    "day": null,
                    "year": 2019
                },
                "end": {
                    "month": 6,
                    "day": null,
                    "year": 2020
                }
            },
            "profile_positions": [
                {
                    "location": "Moscow, Russia",
                    "date": {
                        "start": {
                            "month": 6,
                            "day": null,
                            "year": 2019
                        },
                        "end": {
                            "month": 6,
                            "day": null,
                            "year": 2020
                        }
                    },
                    "company": "Pharmstandard JSC (Pharmstandard Ventures)",
                    "description": null,
                    "title": "Intern",
                    "employment_type": "Internship"
                }
            ]
        }
    ],
    "volunteer_experiences": [],
    "skills": [
        "Venture Capital",
        "Market Research",
        "Financial Modeling",
        "Clinical Trials",
        "Business Development",
        "Life Science Industry",
        "Healthcare Industry",
        "Scientific Analysis",
        "Market research (Pharma&Biotech)",
        "Valuation (DCF, NPV, IRR, Comparabels)",
        "Stock Market Analysis",
        "Negotiation",
        "Start-ups scouting",
        "Competitive Analysis",
        "Patent Analysis",
        "Molecular Diagnostics",
        "Aptamers",
        "Bioanalytical Chemistry",
        "Nanoparticles",
        "Viruses"
    ],
    "network_info": null,
    "related_profiles": null,
    "contact_info": null
}